Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

EXCLUSIVE: Two brothers were shocked when diagnosed with prostate cancer within a month of each other. But luckily that ...

A study shows that ctDNA tests can detect tumours up to three years before before traditional testing methods would have ...

The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Bengaluru: Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide, including in India.

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

The global cancer biopsy market is estimated to be valued at USD 35.8 billion in 2025 and is projected to reach USD 195.5 ...

A team of researchers from the Te Whai Ao Dodd-Walls Centre have developed a potential gamechanger in the detection and ...